Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for May 2011
May 2, 2011
- Teva to Acquire Cephalon in $6.8 Billion Transaction
- ERT Announces Appointment of New President and CEO
- Spectrum Wins Expanded Use for Drug Fusilev
- Abbott Gets FDA Clearance for New Testosterone Gel
- Targacept to Retain Full Rights for TC-5619
- Ranbaxy's Lipitor Copy Fate Decided This Week
- Teva Acquires Cephalon for $6.8 Billion
May 3, 2011
- Pfizer Reports First-Quarter 2011 Results
- Akorn Reports First Quarter 2011 Financial Results
- Icagen Forms Collaboration With Yale School of Medicine and Pfizer to Investigate Potential Novel Pain Treatments
- Mylan's First Quarter 2011 Adjusted Diluted EPS Increases 22% to $0.44
- Ipsen's first quarter 2011 sales
- First-Quarter Profits Up for Mylan
- Bristol-Myers Squibb Initiates A Nationwide Voluntary Recall of Coumadin (Warfarin Sodium) Crystalline 5 mg Tablets, Lot Number 9H49374A
- Keryx Says More EU Kidney Drug Trials Unneeded
- Digital Push Drives Opportunities for Healthcare Agencies: PharmaLive Special Report
- FDA Sends Forest Letter Over Sales Rep's Statement Regarding Savella
- FDA Sends Warning Letter to Three Rivers Pharmaceuticals Over Infergen STATgram
- American Regent Resumes Shipment of Venofer (iron sucrose injection, USP)
May 4, 2011
- First quarter report 2011 - Lundbeck is off to a good start in 2011 as key products maintain momentum
- FTC Staff Report Finds 60 Percent Increase in Pharmaceutical Industry Deals That Delay Consumers' Access to Lower-Cost Generic Drugs
- 75% of U.S. Physicians Own Some Form of Apple Device According to New Manhattan Research Study
- Many New Drugs Did Not Have Comparative Effectiveness Information Available at Time of FDA Approval
- Health Decisions Launches Advanced Strategic Development Division to Ensure Faster and More Efficient Drug Studies
- Allergan Reports First Quarter 2011 Operating Results
- S*BIO Restructures Agreement With Onyx for JAK2 Inhibitor Program
- Actelion to Appeal Final Jury Verdict in Asahi Kasei Litigation in US Court
- Allergan and Molecular Partners Enter Into an Exclusive License Agreement for MP0112 for the Treatment of Retinal Diseases
- Global Orthopedics Industry Reached $30 Billion in 2010: PharmaLive Special Report
- Your Medical Record is Likely for Sale, Doctors Warn
- Extend Health Q1 2011 Medicare Confidence Survey: 60% of Seniors Remain ?Confident? in Medicare
- EMD Serono Announces Civil Settlement
May 5, 2011
- Generic Biotech Drugs Part of Health Overhaul Law
- Big Savings Coming From Emerging Generic Drugs, Patent Expirations
- Serono to Pay $44.3 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Rebif
- INC Research to Acquire Kendle International for $15.25 per Share in Cash
- Par 1Q Profit Falls on Costs, Lower Sales
May 6, 2011
- Rigel Assumes Development Responsibility for Inhaled Asthma Therapy
- FDA Panel Oks Novartis' Pancreatic Tumor Drug
- Warner Chilcott 1Q Loss Widens on Tax Costs
- Advanced Life Sciences Suspends Operations
- Enzon 1Q Profit Plunges on Loss of Revenue
- Canadian Supreme Court Grants Leave to Appeal in Viagra Patent Case
- Ranbaxy Shares Fall By 8.7 Percent After Report of $1 Billion US FDA Fine
- American Regent Resumes Shipment of Injectable Products
May 9, 2011
- Elsevier Acquires Fisterra.Com, an E-Clinical Reference Solution for Spanish Primary Care Professionals
- Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
- Biogen Idec and Swedish Orphan Biovitrum Receive Opinion from EMA on Pediatric Plan for Long-Lasting Hemophilia B Therapy
- J&J Files New Concerta Lawsuit Against Impax Labs
- Sanofi-Aventis Shortens Name to Sanofi
- Report: Antibiotic Research and Revenue Declining
- Warner Chilcott Gets Letter Under FDA 'Bad Ad Program'
- The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer
May 10, 2011
- JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Treatment of Type 1 Diabetes
- FDA Grants Fast Track Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
- EpiCept Files Protocol with FDA for Ceplene Phase III Confirmatory Trial
- Lawsuit: Pfizer Stop-Smoking Med Caused Murder-Suicide
- Isis to Submit Cholesterol Drug to FDA
- J&J's Remicade Meets Ulcerative Colitis Study Goal
- Health Professionals Surveyed Report Concerns About Bias in Commercially-Funded Continuing Medical Education, but Generally Were Reluctant to Fund It Differently
- FDA Requests Input on Development of User Fee Program for Biosimilar and Interchangeable Biological Products
- Forest Laboratories, Inc. Receives Subpoena on Benicar, Benicar HCT and Azor
- Biotech Drug Approvals in the U.S. Nearly Doubled in the Last Decade, According to Tufts Center for the Study of Drug Development
- Mannkind Faces Steep Challenges
- Valeant May Try to Buy Salix
- Apotex Resumes Shipping to the U.S.
- Boston Scientific Announces Retirement of Ray Elliott as President and CEO Effective End of 2011
- Yaz Birth Control Lawsuit: New Jersey Mother Charges Yaz Birth Control Drug Caused Daughter's Death
May 11, 2011
- New Drug Applications Submitted in the United States and Europe for Vemurafenib in Advanced Skin Cancer
- Teva Reports First Quarter 2011 Results
- Yaz Birth Control Lawsuit: New Jersey Mother Charges Yaz Birth Control Drug Caused Daughter's Death
- Public Citizen Exposes Serious Omissions in Published Study of Experimental Procedure for Diagnosing Alzheimer?s Disease
- Allos Therapeutics and Mundipharma Announce Strategic Collaboration for Folotyn
- New Drug Applications Submitted in the United States and Europe for Vemurafenib in Advanced Skin Cancer
- Sanofi Pasteur Launches Pentaxim, First 5-in-1 Combination Vaccine in China
- Janssen Identifies Trace Amounts of TBA in 5 Batches of Prezista (Darunavir) in the EU and Canada
- Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation
May 12, 2011
- Manhattan Research's Taking the Pulse Global Series Reveals Significant Pharma Digital Marketing Opportunities in Emerging Markets
- Pharmaceutical Industry and University Create Manchester Collaborative Centre for Inflammation Research
- More Than 850 Medicines in Development for Diseases That Disproportionately Strike Women
May 13, 2011
- Pfizer Details New Costs to Settle Some Litigation
- Tranzyme's Costs and Revenue Rise
- Biotech Company Adds Jobs for New Business
- Anti-Cancer Therapy Developer Oncolytics Biotech Narrows Q1 Loss to $4M
- Statement about Media Articles as to Takeda's Acquisition of a Swiss Company
- Start up of clinical phase III study with Lu AA21004 in Japan
- Merck Announces Successful Completion of Tender Offer for Shares of Inspire Pharmaceuticals, Inc. With Over 75 Percent of Shares Tendered
- Vaccine To 'Wipe Out' Aids Virus
- Start-Up Helps Patients Help Themselves
- Nuvo Research Completes Its Acquisition of ZARS Pharma
May 16, 2011
- Teva Pharmaceutical to Buy Taiyo Pharmaceutical
- Amylin Pharmaceuticals Files Suit Against Eli Lilly
- Seven Percent of U.S. Physicians Use Video Chat to Communicate with Patients
- Biogen Idec's Fampyra Approved in Australia
- Alexion Pharmaceuticals Expanding in Rhode Island
- Teva Pharma Buys Majority Stake in Taiyo for $460M
- Siga's Smallpox Contract Is Protested By A Rival
- FDA Approves Merck Hepatitis C Drug Shown to Significantly Boost Cure Rate
- Lilly Provides Statement in Response to Amylin Lawsuit
- Man Wanted Hair, but Got the Side Effects, Lawsuit Says
- Teva to Acquire Taiyo
- Merck Completes Acquisition of Inspire Pharmaceuticals, Inc.
- Breckenridge Pharmaceutical Announces Settlement of Actos (Pioglitazone Hydrochloride) Patent Litigation
May 17, 2011
- Last Plaintiff in HIV-tainted Blood Scandal Reaches Settlement
- VistaGen Therapeutics and Excaliber Enterprises Announce Completion of Reverse Merger and $3.8 Million Financing
- Pfizer Seeks US, Japan Approval of Cancer Drug
- Pfizer to Settle Remaining Hormone Therapy Lawsuits for $300 Million Minimum
- Publicis Groupe to Acquire Rosetta, One of the Fastest Growing Digital Marketing Agencies in North America
- Eisai's Halaven Receives Approval From Swissmedic for Use in Late-Stage Metastatic Breast Cancer
- Baxter, UCB, TRI-VIZOR and H.Essers Announce World?s First Example of ?Orchestrated Carpooling for Cargo?
- JLL Partners Sells PharmaNet
- ERYtech Pharma to Partner with Teva for Long Term Distribution Agreement in Israel
May 18, 2011
- Shire to Buy Advanced BioHealing for $750 Million
- Thermo Fisher Scientific Acquires Leading UK Provider of Laboratory Specialty Products
- Evotec AG: Phase II study with NR2B sub-type selective NMDA antagonist in treatment-resistant depression voluntarily terminated
- Amgen Bone Treatment Shows Promise in Cancer Study
- Shire Slips After $750m US Wound Healing Deal
- Statement about Media Articles as to Takeda?s Acquisition of a Swiss Company
- IMS Institute Forecasts Global Spending on Medicines to Reach Nearly $1.1 Trillion by 2015
- Clinipace Expands Overseas With Deal
- NJ Chemist Pleads Not Guilty to Poisoning Husband
- Cancer Drug Use and Spending to Rise Sharply by 2013
May 19, 2011
- Takeda to Acquire Nycomed
- Enzon Announces Discontinuation of PEG-SN38 Program in Metastatic Colorectal Carcinoma in Light of Evolving Standards of Care
- HTG Raises Capital to Increase Workforce, Expand
- Biotech Firm to Add 160 Jobs in Missouri
- Verizon Wireless and Medco Unveil First Mobile Medication App with Real-Time Patient-Specific Drug Safety and Savings Information
- NC House Delays Votes on Protecting Drug Makers
May 20, 2011
- Abbott Statement on the FDA Advisory Committee Recommendations on Fenofibric Acid
- Stanford Medical Faculty Disciplined By School
- Kohl: FTC Should Consider Drug Production Capacity, Potential Shortages in Merger Review
- The EMA Recommends Suspension of Oral Buflomedil-Containing Medicines
- European Committee Endorses Benlysta for Approval
- Pfizer Asks FDA to Speed Review of Cancer Drug
- Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation
May 21, 2011
May 24, 2011
- Valeant Pharma in $441M Deal for AB Sanitas
- Feds' OK of Hepatitis C Drug Will Aid Patients
- Lilly Helps Create Biotech to Develop, Sell Xigris
- Glaxo to Reinvest £3.5 Million of Africa Profits in Healthcare
- Johnson & Johnson Acquiring Russian OTC Products
- European Medicines Agency Responds to Criticism Over Transparency in British Medical Journal
- PRSA: Health Care Industry Needs FDA to Act Soon on Social Media Guidance
- Cilag GmbH International Announces Definitive Agreements to Acquire The Over-The-Counter Brands of J B Chemicals & Pharmaceuticals Limited
- Alcon Wins Patanol US Patent Infringement Lawsuit Against Apotex
May 25, 2011
- Law Change Allows Cheaper Generic Versions of Biotech Drugs
- Sens. Baucus, Grassley Report Details Financial Relationship Between Drug Company, Physicians Who Lobbied the FDA
- Joint House/Senate Inquiry Into Pricing of URL Pharma?s Colcrys, Avanir?s Nuedexta Begins
- Communication Agencies Adjust to Pharma?s Interactive Needs: PharmaLive Special Report
- Angeion Announces CEO Departure and Names Interim CEO
May 26, 2011
- More Women Suing Bayer Unit
- Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
- Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
- Lilly Comments on Court Ruling in Amylin Litigation
- Biocryst Appoints Pharma Veteran As New CFO
- Genentech Scientists Report Antibody Delivery Into Brain
- Roche and TeaRx Ltd. Sign License Agreement for Innovative Drugs Fighting Thrombosis, Stroke, and Embolism
- Pfizer Announces New Strategic Partnerships With ICON And PAREXEL International Corporation
- European Panel Optimistic About Pfizer Arthritis Drug
May 27, 2011
- FDA Sends Noven Pharmaceuticals Letter for 'Misleading' Pexeva Flash Card
- Mylan to Rebrand Matrix Laboratories
- Bayer to Cut 540 Jobs in California
- New SEC Rules Could Lead to More Whistle Blowing
- Cubist Pharma Rises on Talks of Sale to Shire
- Dr. Joseph Sinkule Named as President and Chief Operating Officer of Compass Biotechnologies, Inc.(COBI:OB)
